NCT04220931View on ClinicalTrials.gov

Intrapapillary Botulinum Toxin Injection for PREvention of Post-surgical PAncREactic Fistula

NARecruitingINTERVENTIONAL

Enrollment

460

Participants

Timeline

Start Date

March 27, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

March 1, 2027

Conditions

Distal PancreatectomyPostoperative Pancreatic Fistula

Interventions

DRUG

botulinum toxin injection

injection of Botulinum toxin A 100 UI, single dose administration, in the major papilla, in the Oddi sphincter, during upper gastrointestinal endoscopy.

Trial Locations (1)

92110

RECRUITING

PRAT, Clichy

All Listed Sponsors

lead

Assistance Publique - Hôpitaux de Paris

OTHER